<prompt>  Efavirenz limits HIV infection by :Binding to active site of HIV reverse transcriptaseImpairing the binding of HIV virion to CD4 receptors on TcellsInhibiting the HIV proteaseServing as an allosteric inhibitor of HIV reverse transcriptase 